Postdoctoral position in PET imaging in diabetes and oncology

Sort on published: 2019-01-23

Uppsala University is a comprehensive research-intensive university with a strong international standing. Our mission is to pursue top-quality research and education and to interact constructively with society. Our most important assets are all the individuals whose curiosity and dedication make Uppsala University one of Sweden’s most exciting workplaces. Uppsala University has 42,000 students, 7,000 employees and a turnover of SEK 6.7 billion.

Research group

The research group Theranostics is located by the Rudbeck Laboratory, and is close to the Biomedical Center (BMC) and the Uppsala University Hospital. Olof Eriksson’s lab is associated with Science for Life Laboratory and focuses on development of molecular imaging methodologies for improved diagnosis, management and treatment of metabolic disease and cancer (https://www.scilifelab.se/researchers/olof-eriksson). The research group is a part of the Department of Medicinal Chemistry.

Project description/ duties:

The aim of the project is to develop and evaluate PET radiopharmaceuticals for in vivo molecular imaging of inflammatory processes and beta cell mass. The radiopharmaceuticals will be used to study disease processes in models of diabetes and cancer. The radiopharmaceutical development may include radiolabeling/ radiochemistry, in vitro evaluation (cells and autoradiography) and in vivo evaluation (PET imaging, image analysis, biodistribution and dosimetry). Apart from research, the postdoc may participate in teaching and routine maintenance of the lab. 

Requirements:

We welcome applications from candidates that already have, or who expect to soon have, a PhD degree in biomedicine, engineering, chemistry, natural sciences, pharmacy, medicine or similar, completed a maximum of three (3) years before the final application date. During certain circumstances, an earlier PhD can be acceptable. Certain circumstances include leave due to illness, maternity leave, in trade unions, etc.

The assessment of applications is based primarily on the applicant's ability to conduct independent research based on scientific skill.

Experience of laboratory work including radiochemistry, in vitro (cells/ autoradiography) and in vivo (biodistribution, PET/SPECT/CT/MRI imaging, image analysis) evaluation of radiopharmaceuticals is a strong advantage. Completed courses in laboratory animal science (e.g. FELASA C) or radiation protection are an advantage. The applicant must be fluent in English with excellent communication skills.

Application:

The application should be written in English and contain a cover letter describing the applicant’s research interests and previous experience of research, an updated CV including a list of previous publications, as well as copies of diplomas and certificates of higher academic degrees. Please also attach contact details (name, e-mail, phone number) to at least two referees and/or letters of recommendation.

Selection process: Selection of candidates is based on qualifications, previous work and/or research experience within the field, and personal suitability. Shortlisted candidates will be called for interviews as soon as possible after the application deadline.

Uppsala University strives to be an inclusive workplace that promotes equal opportunities and attracts qualified candidates who can contribute to the University’s excellence and diversity. We welcome applications from all sections of the community and from people of all backgrounds.

Salary: Individually negotiated salary.

Starting date: 2019-04-01 or as soon as possible thereafter.

Position: Temporary position for two years.

Type of Position: 100 %

For further information about the position please contact

Associate Senior Lecturer Olof Eriksson (olof.eriksson@ilk.uu.se)

Please submit your application by March 1, 2019, UFV-PA 2019/6.

Please do not send offers of recruitment or advertising services. Applications must be submitted as described in this advertisement.